One-year survey of paediatric anaphylaxis in an allergy department

 Gaspar1, N Santos2, S Piedade3

  • 1Immunoallergy Department CUF Descobertas Hospital 1998-018 Lisbon, Portugal.

Insights

Food allergy is the leading cause of anaphylaxis in children, with many experiencing recurrent episodes. Epinephrine, a critical treatment, is underused, highlighting the need for better education and management strategies for this severe allergic reaction.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Immunology
  • Epidemiology of Allergic Diseases

Background:

  • Anaphylaxis is a severe, potentially life-threatening allergic reaction.
  • Understanding the epidemiology, triggers, and management of anaphylaxis in children is crucial for effective healthcare.
  • Previous studies have indicated variations in anaphylaxis presentation and management across different populations.

Purpose of the Study:

  • To determine the frequency of anaphylaxis in a pediatric allergy outpatient department.
  • To analyze the aetiology, clinical manifestations, and management of anaphylaxis in children and adolescents.
  • To identify gaps in diagnosis and treatment of anaphylaxis in a pediatric population.

Main Methods:

  • A retrospective analysis of 3646 patients up to 18 years old over a one-year period.
  • Inclusion criteria: patients with a history of anaphylaxis reported by allergists.
  • Data collected on patient demographics, triggers, symptoms, emergency department visits, and treatment, including epinephrine use.

Main Results:

  • Anaphylaxis prevalence was 1.8% (64 children), with a mean age of 8.1 years.
  • The primary trigger was IgE-mediated food allergy (84%), with milk, egg, and peanut being common allergens.
  • Mucocutaneous (94%) and respiratory (84%) symptoms were most frequent; epinephrine was underused (33% of ED visits), and 26% of patients experienced recurrence.

Conclusions:

  • IgE-mediated food allergy is the predominant cause of anaphylaxis in the studied pediatric population.
  • Epinephrine underutilization in emergency settings and delayed specialist assessment are significant concerns.
  • Improved educational programs and systematic reporting are essential for better prevention and management of pediatric anaphylaxis.
Abstract

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
174
Allergic Reactions02:06

Allergic Reactions

Overview
33.6K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
135
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
712
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K